Bollard Group Raised Its Philip Morris Intl (PM) Position; Cytosorbents (CTSO) Sentiment Is 1.27

January 15, 2018 - By Richard Conner

CytoSorbents Corporation, a critical care focused immunotherapy company, engages in the research, development, and commercialization of medical devices with its platform blood purification technology incorporating a proprietary adsorbent, porous polymer technology. The company has market cap of $223.79 million. The Company’s principal product is CytoSorb device, an extracorporeal cytokine filter designed for the adjunctive therapy in the treatment of sepsis; adjunctive therapy in other critical care applications; prevention and treatment of post-operative complications of cardiopulmonary bypass surgery; and prevention and treatment of organ dysfunction in brain-dead organ donors to increase the number and quality of viable organs harvested from donors. It currently has negative earnings. The firm also provides VetResQ device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals.

Bollard Group Llc increased Philip Morris Intl Inc (PM) stake by 19.39% reported in 2017Q3 SEC filing. Bollard Group Llc acquired 16,093 shares as Philip Morris Intl Inc (PM)’s stock rose 10.69%. The Bollard Group Llc holds 99,069 shares with $11.00M value, up from 82,976 last quarter. Philip Morris Intl Inc now has $162.31 billion valuation. The stock decreased 0.34% or $0.36 during the last trading session, reaching $104.5. About 5.51M shares traded or 23.28% up from the average. Philip Morris International Inc. (NYSE:PM) has risen 16.65% since January 15, 2017 and is uptrending. It has underperformed by 0.05% the S&P500.

Among 19 analysts covering Philip Morris International (NYSE:PM), 12 have Buy rating, 0 Sell and 7 Hold. Therefore 63% are positive. Philip Morris International had 49 analyst reports since August 24, 2015 according to SRatingsIntel. As per Friday, October 20, the company rating was maintained by Cowen & Co. Piper Jaffray maintained Philip Morris International Inc. (NYSE:PM) on Thursday, January 11 with “Buy” rating. The stock of Philip Morris International Inc. (NYSE:PM) has “Neutral” rating given on Wednesday, April 20 by Goldman Sachs. The company was maintained on Thursday, August 31 by Stifel Nicolaus. The rating was maintained by Jefferies on Tuesday, September 26 with “Hold”. Piper Jaffray maintained Philip Morris International Inc. (NYSE:PM) rating on Friday, August 18. Piper Jaffray has “Buy” rating and $134.0 target. The firm has “Buy” rating given on Monday, July 17 by Stifel Nicolaus. The firm earned “Buy” rating on Friday, October 13 by Piper Jaffray. The stock of Philip Morris International Inc. (NYSE:PM) has “Buy” rating given on Thursday, July 20 by Cowen & Co. The stock of Philip Morris International Inc. (NYSE:PM) has “Buy” rating given on Monday, August 24 by Vetr.

Bollard Group Llc decreased United States Natl Gas Fund Lp (UNG) stake by 262,900 shares to 36,750 valued at $241,000 in 2017Q3. It also reduced Buckeye Partners Lp (NYSE:BPL) stake by 213,054 shares and now owns 58,981 shares. Exxon Mobil Corp (NYSE:XOM) was reduced too.

Since August 30, 2017, it had 0 insider purchases, and 2 insider sales for $13.44 million activity. On Tuesday, October 24 CAMILLERI LOUIS C sold $11.81 million worth of Philip Morris International Inc. (NYSE:PM) or 108,979 shares. 14,000 shares were sold by Azinovic Drago, worth $1.62 million on Wednesday, August 30.

Investors sentiment increased to 0.97 in Q3 2017. Its up 0.09, from 0.88 in 2017Q2. It increased, as 55 investors sold PM shares while 524 reduced holdings. 112 funds opened positions while 452 raised stakes. 1.10 billion shares or 0.12% more from 1.10 billion shares in 2017Q2 were reported. The Illinois-based Balyasny Asset Mgmt Limited Liability Com has invested 0.02% in Philip Morris International Inc. (NYSE:PM). Cullen Frost Bankers accumulated 97,645 shares. Inr Advisory Svcs Ltd Liability Com accumulated 1,650 shares. Woodmont Counsel Limited Liability holds 0.07% of its portfolio in Philip Morris International Inc. (NYSE:PM) for 2,154 shares. Avalon Advsr Ltd Limited Liability Company owns 348,911 shares or 1.23% of their US portfolio. Farmers Merchants holds 0.03% in Philip Morris International Inc. (NYSE:PM) or 3,017 shares. 20,599 were accumulated by Burke & Herbert Comml Bank &. Fayez Sarofim stated it has 15.70M shares. Reliance Tru Of Delaware holds 38,405 shares. Advantus Mgmt Inc reported 0.45% of its portfolio in Philip Morris International Inc. (NYSE:PM). M&R Mngmt holds 0.21% of its portfolio in Philip Morris International Inc. (NYSE:PM) for 7,785 shares. Commonwealth Of Pennsylvania School Empls Retrmt reported 126,312 shares stake. Chemung Canal Trust reported 0.1% in Philip Morris International Inc. (NYSE:PM). Lee Danner Bass Inc holds 0.89% or 74,624 shares. Rathbone Brothers Plc holds 1.42% or 293,738 shares.

The stock increased 2.63% or $0.2 during the last trading session, reaching $7.8. About 176,874 shares traded or 33.35% up from the average. Cytosorbents Corporation (CTSO) has declined 4.26% since January 15, 2017 and is downtrending. It has underperformed by 20.96% the S&P500.

Manatuck Hill Partners Llc holds 0.45% of its portfolio in Cytosorbents Corporation for 150,000 shares. Skylands Capital Llc owns 500,050 shares or 0.41% of their US portfolio. Moreover, Fortaleza Asset Management Inc has 0.27% invested in the company for 23,375 shares. The North Carolina-based Salem Investment Counselors Inc has invested 0.01% in the stock. Thompson Davis & Co. Inc., a Virginia-based fund reported 1,000 shares.

Analysts await Cytosorbents Corporation (NASDAQ:CTSO) to report earnings on March, 2. They expect $-0.10 EPS, up 37.50% or $0.06 from last year’s $-0.16 per share. After $-0.07 actual EPS reported by Cytosorbents Corporation for the previous quarter, Wall Street now forecasts 42.86% negative EPS growth.

Since January 1, 0001, it had 0 insider purchases, and 1 insider sale for $236,400 activity.